Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA

C-Reactive Protein and Markers for Thrombophilia in Patients with Chronic Plaque Psoriasis

(2017) P. Gisondi et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with Golimumab

(2016) J. Braun et al.   JOURNAL OF RHEUMATOLOGY

Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes

(2015) J. Bonneau et al.   AUTOIMMUNITY REVIEWS

Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis

(2015) Smriti K Raychaudhuri et al.   CLINICAL RHEUMATOLOGY

Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

(2015) Emily K. Wright et al.   GASTROENTEROLOGY

Decreases in diagnostic delay are supported by sensitivity analyses

(2014) J Sørensen et al.   ANNALS OF THE RHEUMATIC DISEASES

Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis

(2014) Maureen C Turina et al.   ANNALS OF THE RHEUMATIC DISEASES

Assessment of Lipocalin 2, Clusterin, Soluble Tumor Necrosis Factor Receptor-1, Interleukin-6, Homocysteine, and Uric Acid Levels in Patients with Psoriasis

(2014) Arzu Ataseven et al.   DISEASE MARKERS

Meta-analysis

(2014) Jin-Feng Lin et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis

(2014) Kenia Rodrigues de Andrade et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Serum Vascular Endothelial Growth Factor, Transforming Growth Factor β1, and Nitric Oxide Levels in Patients With Psoriasis Vulgaris: Their Correlation to Disease Severity

(2014) Abdel-Raheim M. A. Meki et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease

(2014) Roman M Janas et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum Leptin and Adiponectin Levels in Korean Patients with Psoriasis

(2014) Yu Jin Oh et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis

(2014) E. Klingberg et al.   JOURNAL OF RHEUMATOLOGY

Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor

(2014) Leyla Didem Kozaci et al.   Modern Rheumatology

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

(2014) Kaija-Leena Kolho et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease

(2014) Bülent Yılmaz   WORLD JOURNAL OF GASTROENTEROLOGY

Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

(2013) Fernanda Genre et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis: Table 1

(2013) X Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoantibodies against CD74 in spondyloarthritis

(2013) N T Baerlecken et al.   ANNALS OF THE RHEUMATIC DISEASES

Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis

(2013) Denis Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome

(2013) H. El-Hadidi et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage

(2013) Mariusz Korkosz et al.   BMC MUSCULOSKELETAL DISORDERS

Leptin levels in patients with psoriasis: a meta-analysis

(2013) K.-J. Zhu et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

The Effect of Acitretin Treatment on Insulin Resistance, Retinol-Binding Protein-4, Leptin, and Adiponectin in Psoriasis Vulgaris: A Noncontrolled Study

(2013) Ayse Serap Karadag et al.   DERMATOLOGY

High Serum Vaspin Concentrations in Patients with Ulcerative Colitis

(2013) Tomohito Morisaki et al.   DIGESTIVE DISEASES AND SCIENCES

Relationship Between Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Inflammatory Bowel Disease Type and Activity

(2013) Atakan Yeşil et al.   DIGESTIVE DISEASES AND SCIENCES

S100A8-S100A9 Protein Complex Mediates Psoriasis by Regulating the Expression of Complement Factor C3

(2013) Helia B. Schonthaler et al.   IMMUNITY

Serum calprotectin as a biomarker for Crohn's disease

(2013) M.-A. Meuwis et al.   Journal of Crohns & Colitis

Effect of Narrow-Band UVB Phototherapy on Soluble Cell Adhesion Molecules in Patients with Psoriasis Vulgaris

(2013) JW Long et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

C-reactive protein in psoriasis: a review of the literature

(2013) S. Beygi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

(2012) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model

(2012) Liesbet Van Praet et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis

(2012) Jacqueline E Paramarta et al.   ANNALS OF THE RHEUMATIC DISEASES

Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI

(2012) Jorge Romaní et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters

(2012) T. Gambichler et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2-microglobulin-transgenic rat model of spondylarthritis

(2012) Leonie M. van Duivenvoorde et al.   ARTHRITIS AND RHEUMATISM

Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?

(2012) Dominique Baeten et al.   ARTHRITIS AND RHEUMATISM

Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis

(2012) Ali Taylan et al.   BMC MUSCULOSKELETAL DISORDERS

Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab

(2012) P. Gisondi et al.   BRITISH JOURNAL OF DERMATOLOGY

Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a)

(2012) Houshang Nemati et al.   CELL BIOCHEMISTRY AND FUNCTION

Serum lipocalin-2 levels are increased in patients with psoriasis

(2012) M. Kamata et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease

(2012) V. S. Rodrigues et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin

(2012) Mustafa ÖZDEMIR et al.   JOURNAL OF DERMATOLOGY

Detection of Multiple Autoantibodies in Patients with Ankylosing Spondylitis Using Nucleic Acid Programmable Protein Arrays

(2012) Cynthia Wright et al.   MOLECULAR & CELLULAR PROTEOMICS

Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis

(2012) Lei Zhang et al.   PLoS One

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis

(2011) Gisela Ruiz Heiland et al.   ANNALS OF THE RHEUMATIC DISEASES

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

(2011) D. Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and c

(2011) Susanne Juhl Pedersen et al.   ARTHRITIS AND RHEUMATISM

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

(2011) Matthias Jürgens et al.   Clinical Gastroenterology and Hepatology

New IBD genetics: common pathways with other diseases

(2011) C. W. Lees et al.   GUT

Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review

(2011) Lani Prideaux et al.   INFLAMMATORY BOWEL DISEASES

High-sensitivity C-reactive protein in psoriasis

(2011) Nuzhatun Nisa et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

(2011) K. A. Oikonomou et al.   JOURNAL OF GASTROENTEROLOGY

Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations

(2011) I. Flisiak et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Spondyloarthritis

(2011) Maxime Dougados et al.   LANCET

Phototherapy reduces serum resistin levels in psoriasis patients

(2011) Kana Kawashima et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

(2011) Paola Di Meglio et al.   PLoS One

Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses

(2011) R. Sarin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy

(2011) Seong-Ryul Kwon et al.   RHEUMATOLOGY INTERNATIONAL

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

(2011) Anssi Hämäläinen   WORLD JOURNAL OF GASTROENTEROLOGY

Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

(2011) Heiner Appel et al.   ARTHRITIS RESEARCH & THERAPY

Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn’s disease

(2010) A. Oussalah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

(2010) D. Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

(2010) M. Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

(2010) Anastassios C Manolakis et al.   BMC GASTROENTEROLOGY

Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy

(2010) S. Coimbra et al.   BRITISH JOURNAL OF DERMATOLOGY

Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis

(2010) Chen-Liang Chou et al.   CLINICAL RHEUMATOLOGY

Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study

(2010) Gian Luca Erre et al.   CLINICAL RHEUMATOLOGY

Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors

(2010) Susanne Juhl Pedersen et al.   CLINICAL RHEUMATOLOGY

New Serologic Markers for Inflammatory Bowel Disease Diagnosis

(2010) Iris Dotan   DIGESTIVE DISEASES

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

(2010) Marko Brinar et al.   GUT

Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: Association with other clinical and laboratory parameters

(2010) Ádám Kemény-Beke et al.   JOINT BONE SPINE

pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease

(2010) M. de VRIES et al.   JOURNAL OF RHEUMATOLOGY

Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy

(2010) S Coimbra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

(2010) John D Reveille et al.   NATURE GENETICS

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes

(2010) Karin Malíčková et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value

(2010) Evgenija Homšak et al.   WIENER KLINISCHE WOCHENSCHRIFT

Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis

(2009) L. Melis et al.   ANNALS OF THE RHEUMATIC DISEASES

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

(2009) J Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

(2009) Heiner Appel et al.   ARTHRITIS AND RHEUMATISM

HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats

(2009) Monica L. DeLay et al.   ARTHRITIS AND RHEUMATISM

Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis

(2009) Mirjam K. de Vries et al.   ARTHRITIS AND RHEUMATISM

Serum cytokines and growth factor levels in Japanese patients with psoriasis

(2009) H. Takahashi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Investigating the genetic association between ERAP1 and ankylosing spondylitis

(2009) David Harvey et al.   HUMAN MOLECULAR GENETICS

Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease

(2009) N. Yamaguchi et al.   INFLAMMATION RESEARCH

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohnʼs disease

(2009) Johanna Weigert et al.   INFLAMMATORY BOWEL DISEASES

Fetuin-A and interleukin-18 levels in ankylosing spondylitis

(2009) Ismail SARI et al.   International Journal of Rheumatic Diseases

Serum high molecular weight adiponectin levels are decreased in psoriasis patients

(2009) Sayaka Shibata et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy

(2009) S Coimbra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin

(2009) Patrick A. M. Jansen et al.   PLoS One

Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein

(2009) M. Benhamou et al.   RHEUMATOLOGY

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

(2009) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease

(2009) Carlo Salvarani et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease

(2009) Wei-Bing Song et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Increased plasma ghrelin following infliximab in Crohn’s disease

(2008) E. Z. H. SUNG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation

(2008) A. Johnston et al.   BRITISH JOURNAL OF DERMATOLOGY

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis

(2008) B. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY

Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β inductionvia X-box binding protein 1

(2008) Judith A. Smith et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

(2008) M. Caproni et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Leptin, adiponectin, resistin, and ghrelin - Implications for inflammatory bowel disease

(2008) Konstantinos Karmiris et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

(2008) Michael Wagner et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease

(2007) Yusuf Erzin et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY